![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 9/00 | |
A61K 47/10 | |||
A61K 9/10 | |||
A61K 9/14 | |||
C07D 491/107 | |||
A61K 31/517 | |||
A61P 35/00 | |||
A61P 27/02 |
(11) | Number of the document | 3062618 |
(13) | Kind of document | T |
(96) | European patent application number | 14857737.2 |
Date of filing the European patent application | 2014-10-31 | |
(97) | Date of publication of the European application | 2016-09-07 |
(45) | Date of publication and mention of the grant of the patent | 2020-02-05 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2014/063444 |
Date | 2014-10-31 |
(87) | Number | WO 2015/066482 |
Date | 2015-05-07 |
(30) | Number | Date | Country code |
201361898741 P | 2013-11-01 | US | |
201462039177 P | 2014-08-19 | US | |
201462039192 P | 2014-08-19 | US |
(72) |
ENLOW, Elizabeth, US
NGUYEN, Minh Ngoc, US
ONG, Winston Z., US
|
(73) |
Kala Pharmaceuticals, Inc.,
490 Arsenal Way, Suite 120, Watertown, MA 02472,
US
|
(54) | CRYSTALLINE FORMS OF THERAPEUTIC COMPOUNDS AND USES THEREOF |
CRYSTALLINE FORMS OF THERAPEUTIC COMPOUNDS AND USES THEREOF |